Two non-psychoactive cannabis compounds, cannabidiol (CBD) and cannabigerol (CBG), could offer new treatment options for metabolic dysfunction-associated steatotic liver disease (MASLD), according to research published in…
Researchers from Johns Hopkins University have found that psilocybin could be used as a tool in the fight against post-treatment Lyme disease (PTLD), a currently untreatable…
A preclinical study, published in the journal Pharmacological Research, has found that regular administration of very low doses of psilocybin improved metabolic health in mice with…
